// App-Quantinova.ai

: Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED

Researchers

Presenter

  • Nazanin Zounemat Kermani

Principal Investigators

  • Mansoor Saqi

  • Yike Guo

  • Paul Agapow

  • Chih-Hsi Kuo

  • Matthew Loza

  • Frederic Baribaud

  • Anthony Rowe

  • Ana Sousa

  • Bertrand De Meulder

  • Diane Lefaudeux

  • Louise Fleming

  • Julie Corfield

  • Richard Knowles

  • Charles Auffray

  • Ratko Djukanovic

  • Peter J. Sterk

  • Ian Adcock

  • Fan Chung

Medical Centers

  • Wright Fleming Institute, Imperial College London, London, United Kingdom

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Janssen R&D, Spring House, United States of America

  • GlaxoSmithKline, Stockley Park, United Kingdom

  • European Institute of Systems Biology and Medicine, Lyon, France

  • Hammersmith Hospital, Imperial College, London, United Kingdom

  • Areteva Ltd, Nottingham, United Kingdom,

  • Knowles Consulting, Stevenage, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Locations

  • United Kingdom

  • United States

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Asthma

  • Spondylocostal dysostosis 5

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved